OSU-T315: A novel targeted therapeutic that antagonizes AKT membrane localization and activation of chronic lymphocytic leukemia cells

Ta Ming Liu, Yonghua Ling, Jennifer A. Woyach, Kyle Beckwith, Yuh Ying Yeh, Erin Hertlein, Xiaoli Zhang, Amy Lehman, Farrukh Awan, Jeffrey A. Jones, Leslie A. Andritsos, Kami Maddocks, Jessica MacMurray, Santosh B. Salunke, Ching Shih Chen, Mitch A. Phelps, John C. Byrd, Amy J. Johnson

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'OSU-T315: A novel targeted therapeutic that antagonizes AKT membrane localization and activation of chronic lymphocytic leukemia cells'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds